You are here

Novo Nordisk

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India

Reuters

Fri, 10/11/24 - 09:42 am

artificial intelligence

Weight loss gold rush: Developers vie for next blockbuster treatment

Pharmaphorum

Tue, 10/8/24 - 09:45 am

Boehringer Ingelheim

Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case

Fierce Pharma

Mon, 10/7/24 - 09:56 pm

Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds

Pharma Voice

Mon, 10/7/24 - 11:23 am

cardiovascular disease

artificial intelligence

Dandelion Health

Novo Nordisk has mitigation plans to minimize disruption from port strikes

Reuters

Thu, 10/3/24 - 11:47 am

Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings

Forbes

Wed, 10/2/24 - 11:20 am

Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro

Beckers Hospital Review

Tue, 10/1/24 - 10:45 am

Evotec and Novo Nordisk in technology development partnership

Reuters

Thu, 09/26/24 - 11:16 am

Ozempic linked to lower opioid overdose rate in those with diabetes, study shows

Stat

Wed, 09/25/24 - 12:04 pm

opioid addiction

type 2 diabetes

With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight

Fierce Pharma

Tue, 09/24/24 - 10:11 pm

Lars Fruergaard Jorgensen

Inside the GLP-1 'price war'

Beckers Hospital Review

Tue, 09/24/24 - 11:52 am

U.S. Senator Sanders says pharmacy middlemen commit to expanding weight-loss drug coverage if prices cut

Reuters

Tue, 09/24/24 - 11:40 am

Novo says Ozempic to be eligible for US price negotiations in less than a year

Reuters

Mon, 09/23/24 - 10:27 pm

Novo Nordisk faces US congressional grilling over price of weight loss drugs

Reuters

Mon, 09/23/24 - 09:49 am

Novo obesity prospect linked to ‘mild to moderate neuropsychiatric side effects’ in phase 2

Fierce Biotech

Fri, 09/20/24 - 11:30 am

clinical trials

EU regulator backs use of Novo's Wegovy for obesity-related heart condition

Reuters

Thu, 09/19/24 - 09:16 pm

heart failure with preserved ejection fraction

Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver

Fierce Biotech

Wed, 09/18/24 - 01:23 pm

NanoVation Therapeutics

genetic medicine

US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month

Reuters

Tue, 09/17/24 - 11:11 pm

Obesity pill race heats up as Novo, Roche and Terns share data

BioSpace

Tue, 09/17/24 - 11:22 am

Terns Pharmaceuticals

clinical trials

Pages